Drugs / Glimepiride/metformin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00612144 | Dec 2007 → May 2009 | type 2 diabetes mellitus | Handok Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glimepiride/metformin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00612144 ↗ |
| Known as | G/M FDC | “received glimepiride/metformin fixed-dose combination (G/M FDC) or metformin uptitration treatment (Met UP).” PMID 25422771 ↗ Mar 2014 |